why choose us

First received: November 30, 2022

Clinical Trial: Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Study Status: Completed

Recruit Status: Completed

Condition: COVID-19

Study Type: Interventional


Official Title: A Multi-Center Single Arm, Open-label, Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Brief Summary: This study is a multi-center, single-arm, open-label, pilot clinical trial to explore efficacy and safety of Pyramax in mild to moderate COVID-19 patients

Read more